PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
23-Sep-2024 Mölnlycke Health Care partners with Ondine for Steriwave distribution collaboration in the key markets of the UK, Europe and the Middle East Ondine Biomedical Inc
23-Sep-2024 2024 ABPI Code of Practice launched, with a new constitution and procedure for the PMCPA Association of the British Pharmaceutical Industry (ABPI)
23-Sep-2024 European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement The European Microbiome Innovation for Health
23-Sep-2024 Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer Theriva™ Biologics, Inc.
19-Sep-2024 Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer Autolus Therapeutics plc
19-Sep-2024 New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment TG THERAPEUTICS
19-Sep-2024 Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems Biognosys
19-Sep-2024 Poolbeg Pharma plc - Interim results for the six months to 30 June 2024 Poolbeg Pharma plc
17-Sep-2024 AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease AC Immune SA
17-Sep-2024 Improved breast cancer risk tools on the horizon as major study reaches 20-year halfway point The Institute of Cancer Research
17-Sep-2024 Galapagos receives transparency notification from EcoR1 Capital Galapagos
17-Sep-2024 MinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus MinervaX
17-Sep-2024 A global pharma showcase: MM Packaging readies for CPHI 2024 MM Packaging
17-Sep-2024 OrganaBio Expands Cell and Gene Therapy Donor Base to Include Patients with Lupus, Other Autoimmune Diseases OrganaBio
17-Sep-2024 ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics Verismo Therapeutics
17-Sep-2024 AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease AC Immune SA
17-Sep-2024 ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base ImmunOs Therapeutics
16-Sep-2024 Refeyn establishes new mass photometry Scientific Advisory Board to maximize potential of transformative technology Refeyn Ltd
16-Sep-2024 AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B AAVantgarde Bio
16-Sep-2024 Certa Therapeutics Announces International Non-Proprietary Name for its First-in-class GPR68 Inhibitor Asengeprast (FT011) Certa Therapeutics